Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Metrics and benchmarks for HIV transition.

Ghys PD, Over M, Hallett TB, Mahy M, Godfrey-Faussett P.

Lancet HIV. 2019 Mar;6(3):e150. doi: 10.1016/S2352-3018(19)30050-5. No abstract available.

PMID:
30846054
2.

Approaches to Improve the Surveillance, Monitoring, and Management of Noncommunicable Diseases in HIV-Infected Persons: Viewpoint.

Patel P, Sabin K, Godfrey-Faussett P.

JMIR Public Health Surveill. 2018 Dec 20;4(4):e10989. doi: 10.2196/10989.

3.

Epidemiological metrics and benchmarks for a transition in the HIV epidemic.

Ghys PD, Williams BG, Over M, Hallett TB, Godfrey-Faussett P.

PLoS Med. 2018 Oct 25;15(10):e1002678. doi: 10.1371/journal.pmed.1002678. eCollection 2018 Oct.

4.

Ethical considerations in global HIV phylogenetic research.

Coltart CEM, Hoppe A, Parker M, Dawson L, Amon JJ, Simwinga M, Geller G, Henderson G, Laeyendecker O, Tucker JD, Eba P, Novitsky V, Vandamme AM, Seeley J, Dallabetta G, Harling G, Grabowski MK, Godfrey-Faussett P, Fraser C, Cohen MS, Pillay D; Ethics in HIV Phylogenetics Working Group.

Lancet HIV. 2018 Nov;5(11):e656-e666. doi: 10.1016/S2352-3018(18)30134-6. Epub 2018 Aug 30. Review.

PMID:
30174214
5.

Expert consensus statement on the science of HIV in the context of criminal law.

Barré-Sinoussi F, Abdool Karim SS, Albert J, Bekker LG, Beyrer C, Cahn P, Calmy A, Grinsztejn B, Grulich A, Kamarulzaman A, Kumarasamy N, Loutfy MR, El Filali KM, Mboup S, Montaner JS, Munderi P, Pokrovsky V, Vandamme AM, Young B, Godfrey-Faussett P.

J Int AIDS Soc. 2018 Jul;21(7):e25161. doi: 10.1002/jia2.25161.

6.

Socio-economic gradients in prevalent tuberculosis in Zambia and the Western Cape of South Africa.

Yates TA, Ayles H, Leacy FP, Schaap A, Boccia D, Beyers N, Godfrey-Faussett P, Floyd S.

Trop Med Int Health. 2018 Apr;23(4):375-390. doi: 10.1111/tmi.13038. Epub 2018 Mar 24. Erratum in: Trop Med Int Health. 2018 Aug;23(8):934.

7.

Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR).

Bond V, Floyd S, Fenty J, Schaap A, Godfrey-Faussett P, Claassens M, Shanaube K, Ayles H, Hargreaves JR.

Int J Tuberc Lung Dis. 2017 Nov 1;21(11):49-59. doi: 10.5588/ijtld.16.0920.

8.

Impact of Point-of-Care Xpert MTB/RIF on Tuberculosis Treatment Initiation. A Cluster-randomized Trial.

Lessells RJ, Cooke GS, McGrath N, Nicol MP, Newell ML, Godfrey-Faussett P.

Am J Respir Crit Care Med. 2017 Oct 1;196(7):901-910. doi: 10.1164/rccm.201702-0278OC.

9.

The association of hyperglycaemia with prevalent tuberculosis: a population-based cross-sectional study.

Bailey SL, Ayles H, Beyers N, Godfrey-Faussett P, Muyoyeta M, du Toit E, Yudkin JS, Floyd S.

BMC Infect Dis. 2016 Dec 5;16(1):733.

10.

No one left behind: how are we doing in the roll-out of PrEP as part of combination HIV prevention?

Cáceres CF, Bekker LG, Godfrey-Faussett P.

J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21364. doi: 10.7448/IAS.19.7.21364. eCollection 2016. No abstract available.

11.

Diabetes mellitus in Zambia and the Western Cape province of South Africa: Prevalence, risk factors, diagnosis and management.

Bailey SL, Ayles H, Beyers N, Godfrey-Faussett P, Muyoyeta M, du Toit E, Yudkin JS, Floyd S.

Diabetes Res Clin Pract. 2016 Aug;118:1-11. doi: 10.1016/j.diabres.2016.05.001. Epub 2016 May 7.

12.

High burden of prevalent tuberculosis among previously treated people in Southern Africa suggests potential for targeted control interventions.

Marx FM, Floyd S, Ayles H, Godfrey-Faussett P, Beyers N, Cohen T.

Eur Respir J. 2016 Oct;48(4):1227-1230. doi: 10.1183/13993003.00716-2016. Epub 2016 Jul 7. No abstract available.

13.

The HIV prevention cascade: more smoke than thunder?

Godfrey-Faussett P.

Lancet HIV. 2016 Jul;3(7):e286-8. doi: 10.1016/S2352-3018(16)30062-5. No abstract available.

14.

Coverage of clinic-based TB screening in South Africa may be low in key risk groups.

McCreesh N, Faghmous I, Looker C, Dodd PJ, Plumb ID, Shanaube K, Muyoyeta M, Godfrey-Faussett P, Ayles H, White RG.

Public Health Action. 2016 Mar 21;6(1):19-21. doi: 10.5588/pha.15.0064. Epub 2015 Jan 25.

15.

Health care workers' gender bias in testing could contribute to missed tuberculosis among women in South Africa.

Smith A, Burger R, Claassens M, Ayles H, Godfrey-Faussett P, Beyers N.

Int J Tuberc Lung Dis. 2016 Mar;20(3):350-6. doi: 10.5588/ijtld.15.0312.

PMID:
27046716
16.

Why are people living with HIV still dying of tuberculosis?

Godfrey-Faussett P, Ayles H.

Lancet. 2016 Mar 19;387(10024):1141-3. doi: 10.1016/S0140-6736(16)00699-1. No abstract available.

PMID:
27025319
17.

Comparison of indoor contact time data in Zambia and Western Cape, South Africa suggests targeting of interventions to reduce Mycobacterium tuberculosis transmission should be informed by local data.

McCreesh N, Looker C, Dodd PJ, Plumb ID, Shanaube K, Muyoyeta M, Godfrey-Faussett P, Corbett EL, Ayles H, White RG.

BMC Infect Dis. 2016 Feb 9;16:71. doi: 10.1186/s12879-016-1406-5.

18.

Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection.

Dodd PJ, Looker C, Plumb ID, Bond V, Schaap A, Shanaube K, Muyoyeta M, Vynnycky E, Godfrey-Faussett P, Corbett EL, Beyers N, Ayles H, White RG.

Am J Epidemiol. 2016 Jan 15;183(2):156-66. doi: 10.1093/aje/kwv160. Epub 2015 Dec 8.

19.

Symptom reporting among prevalent tuberculosis cases who smoke, are HIV-positive or have hyperglycaemia.

Sattar S, Van Schalkwyk C, Claassens M, Dunbar R, Floyd S, Enarson DA, Godfrey-Faussett P, Ayles H, Beyers N.

Public Health Action. 2014 Dec 21;4(4):222-5. doi: 10.5588/pha.14.0081.

20.

HIV treatment cascade in tuberculosis patients.

Lessells RJ, Swaminathan S, Godfrey-Faussett P.

Curr Opin HIV AIDS. 2015 Nov;10(6):439-46. doi: 10.1097/COH.0000000000000197. Review.

21.

The Second Zambian National Tuberculosis Drug Resistance survey - a comparison of conventional and molecular methods.

Kapata N, Mbulo G, Cobelens F, de Haas P, Schaap A, Mwamba P, Mwanza W, Muvwimi M, Muyoyeta M, Moyo M, Mulenga L, Grobusch MP, Godfrey-Faussett P, Ayles H.

Trop Med Int Health. 2015 Nov;20(11):1492-1500. doi: 10.1111/tmi.12581. Epub 2015 Aug 27.

22.

The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention.

Cáceres CF, Koechlin F, Goicochea P, Sow PS, O'Reilly KR, Mayer KH, Godfrey-Faussett P.

J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):19949. doi: 10.7448/IAS.18.4.19949. eCollection 2015.

23.

Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings.

Muyoyeta M, Moyo M, Kasese N, Ndhlovu M, Milimo D, Mwanza W, Kapata N, Schaap A, Godfrey Faussett P, Ayles H.

PLoS One. 2015 Jun 1;10(6):e0126376. doi: 10.1371/journal.pone.0126376. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0137934.

24.

Applying ethical principles to international community-based research: a case study from the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE) .

Kass NE, DeLuca AN, Coetzee L, Simwinga M, Churchyard GJ, Ayles H, Beyers N, Godfrey-Faussett P, Durovni B, Chaisson RE, Eldred LJ.

IRB. 2014 May-Jun;36(3):1-8. No abstract available.

PMID:
24946506
25.

Effect of home-based interventions on virologic outcomes in adults receiving antiretroviral therapy in Africa: a meta-analysis.

Chishinga N, Godfrey-Faussett P, Fielding K, Ayles H.

BMC Public Health. 2014 Mar 7;14:239. doi: 10.1186/1471-2458-14-239. Review.

26.

A trial of mass isoniazid preventive therapy for tuberculosis control.

Churchyard GJ, Fielding KL, Lewis JJ, Coetzee L, Corbett EL, Godfrey-Faussett P, Hayes RJ, Chaisson RE, Grant AD; Thibela TB Study Team.

N Engl J Med. 2014 Jan 23;370(4):301-10. doi: 10.1056/NEJMoa1214289.

27.

Design of pragmatic trials of tuberculosis interventions - authors' reply.

Ayles H, Floyd S, Beyers N, Godfrey-Faussett P; ZAMSTAR team.

Lancet. 2014 Jan 18;383(9913):214-5. doi: 10.1016/S0140-6736(14)60067-2. No abstract available.

PMID:
24439731
28.

Prevalence and risk factors for infection of bovine tuberculosis in indigenous cattle in the Serengeti ecosystem, Tanzania.

Katale BZ, Mbugi EV, Karimuribo ED, Keyyu JD, Kendall S, Kibiki GS, Godfrey-Faussett P, Michel AL, Kazwala RR, van Helden P, Matee MI.

BMC Vet Res. 2013 Dec 30;9:267. doi: 10.1186/1746-6148-9-267.

29.

Unusual sex differences in tuberculosis notifications across Pakistan and the role of environmental factors.

Khan MS, Khan MS, Hasan R, Godfrey-Faussett P.

East Mediterr Health J. 2013 Sep;19(9):821-5.

30.

Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.

Seddon JA, Hesseling AC, Finlayson H, Fielding K, Cox H, Hughes J, Godfrey-Faussett P, Schaaf HS.

Clin Infect Dis. 2013 Dec;57(12):1676-84. doi: 10.1093/cid/cit655. Epub 2013 Sep 24.

31.

High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study.

Seddon JA, Hesseling AC, Godfrey-Faussett P, Schaaf HS.

Thorax. 2014 May;69(5):458-64. doi: 10.1136/thoraxjnl-2013-203900. Epub 2013 Sep 24.

PMID:
24064441
32.

Risk factors for infection and disease in child contacts of multidrug-resistant tuberculosis: a cross-sectional study.

Seddon JA, Hesseling AC, Godfrey-Faussett P, Fielding K, Schaaf HS.

BMC Infect Dis. 2013 Aug 26;13:392. doi: 10.1186/1471-2334-13-392.

33.

Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial.

Ayles H, Muyoyeta M, Du Toit E, Schaap A, Floyd S, Simwinga M, Shanaube K, Chishinga N, Bond V, Dunbar R, De Haas P, James A, Gey van Pittius NC, Claassens M, Fielding K, Fenty J, Sismanidis C, Hayes RJ, Beyers N, Godfrey-Faussett P; ZAMSTAR team.

Lancet. 2013 Oct 5;382(9899):1183-94. doi: 10.1016/S0140-6736(13)61131-9. Epub 2013 Aug 1.

PMID:
23915882
34.

Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial.

Lessells RJ, Cooke GS, McGrath N, Nicol MP, Newell ML, Godfrey-Faussett P.

Trials. 2013 Jun 12;14:170. doi: 10.1186/1745-6215-14-170.

35.

High prevalence of tuberculosis and insufficient case detection in two communities in the Western Cape, South Africa.

Claassens M, van Schalkwyk C, den Haan L, Floyd S, Dunbar R, van Helden P, Godfrey-Faussett P, Ayles H, Borgdorff M, Enarson D, Beyers N.

PLoS One. 2013;8(4):e58689. doi: 10.1371/journal.pone.0058689. Epub 2013 Apr 1.

36.

Systematic screening for active tuberculosis: rationale, definitions and key considerations.

Lönnroth K, Corbett E, Golub J, Godfrey-Faussett P, Uplekar M, Weil D, Raviglione M.

Int J Tuberc Lung Dis. 2013 Mar;17(3):289-98. doi: 10.5588/ijtld.12.0797. Review.

37.

Tuberculosis cross-species transmission in Tanzania: towards a One-Health concept.

Mbugi EV, Katale BZ, Kendall S, Good L, Kibiki GS, Keyyu JD, Godfrey-Faussett P, Van Helden P, Matee MI.

Onderstepoort J Vet Res. 2012 Jul 20;79(2):501. doi: 10.4102/ojvr.v79i2.501. Review.

PMID:
23327386
38.

'One Health' infectious diseases surveillance in Tanzania: are we all on board the same flight?

Mbugi EV, Kayunze KA, Katale BZ, Kendall S, Good L, Kibik GS, Keyyu JD, Godfrey-Faussett P, Van Helden P, Matee MI.

Onderstepoort J Vet Res. 2012 Jul 19;79(2):500. doi: 10.4102/ojvr.v79i2.500. Review.

PMID:
23327385
39.

Bovine tuberculosis at the human-livestock-wildlife interface: is it a public health problem in Tanzania? A review.

Katale BZ, Mbugi EV, Kendal S, Fyumagwa RD, Kibiki GS, Godfrey-Faussett P, Keyyu JD, Van Helden P, Matee MI.

Onderstepoort J Vet Res. 2012 Jun 20;79(2):463. doi: 10.4102/ojvr.v79i2.463. Review.

40.

The measurement of household socio-economic position in tuberculosis prevalence surveys: a sensitivity analysis.

Boccia D, Hargreaves J, Howe LD, De Stavola BL, Fielding K, Ayles H, Godfrey-Faussett P.

Int J Tuberc Lung Dis. 2013 Jan;17(1):39-45. doi: 10.5588/ijtld.11.0387.

PMID:
23232003
41.

Why do child contacts of multidrug-resistant tuberculosis not come to the assessment clinic?

Zimri K, Hesseling AC, Godfrey-Faussett P, Schaaf HS, Seddon JA.

Public Health Action. 2012 Sep 21;2(3):71-5. doi: 10.5588/pha.12.0024.

42.

Decentralised care for the management of child contacts of multidrug-resistant tuberculosis.

Seddon JA, Hesseling AC, Dunbar R, Cox H, Hughes J, Fielding K, Godfrey-Faussett P, Schaaf HS.

Public Health Action. 2012 Sep 21;2(3):66-70. doi: 10.5588/pha.12.0023.

43.

High levels of vulnerability and anticipated stigma reduce the impetus for tuberculosis diagnosis in Cape Town, South Africa.

Murray EJ, Bond VA, Marais BJ, Godfrey-Faussett P, Ayles HM, Beyers N.

Health Policy Plan. 2013 Jul;28(4):410-8. doi: 10.1093/heapol/czs072. Epub 2012 Sep 2.

PMID:
22945548
44.

Hearing loss in patients on treatment for drug-resistant tuberculosis.

Seddon JA, Godfrey-Faussett P, Jacobs K, Ebrahim A, Hesseling AC, Schaaf HS.

Eur Respir J. 2012 Nov;40(5):1277-86. doi: 10.1183/09031936.00044812. Epub 2012 Jun 14. Review.

45.

Management of children exposed to multidrug-resistant Mycobacterium tuberculosis.

Seddon JA, Godfrey-Faussett P, Hesseling AC, Gie RP, Beyers N, Schaaf HS.

Lancet Infect Dis. 2012 Jun;12(6):469-79. doi: 10.1016/S1473-3099(11)70366-8. Epub 2012 Feb 27. Review.

PMID:
22373591
46.

Factors influencing sex differences in numbers of tuberculosis suspects at diagnostic centres in Pakistan.

Khan MS, Khan MS, Sismanidis C, Godfrey-Faussett P.

Int J Tuberc Lung Dis. 2012 Feb;16(2):172-7. doi: 10.5588/ijtld.11.0265.

PMID:
22236916
47.

Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact.

Lessells RJ, Cooke GS, Newell ML, Godfrey-Faussett P.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1187-95. doi: 10.1093/infdis/jir412. Review.

48.

Delays in seeking treatment for symptomatic tuberculosis in Sabah, East Malaysia: factors for patient delay.

Rundi C, Fielding K, Godfrey-Faussett P, Rodrigues LC, Mangtani P.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1231-8, i. doi: 10.5588/ijtld.10.0585.

PMID:
21943851
49.

The association between household socioeconomic position and prevalent tuberculosis in Zambia: a case-control study.

Boccia D, Hargreaves J, De Stavola BL, Fielding K, Schaap A, Godfrey-Faussett P, Ayles H.

PLoS One. 2011;6(6):e20824. doi: 10.1371/journal.pone.0020824. Epub 2011 Jun 17.

50.

Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.

Shanaube K, Hargreaves J, Fielding K, Schaap A, Lawrence KA, Hensen B, Sismanidis C, Menezes A, Beyers N, Ayles H, Godfrey-Faussett P.

PLoS One. 2011 Apr 4;6(4):e18206. doi: 10.1371/journal.pone.0018206.

Supplemental Content

Loading ...
Support Center